In summary, there is heterogeneity in CD90+ and CD90− fibroblast subpopulations, and CD90+ fibroblasts rely on αvβ3 integrin and WNT signaling pathways to alleviate pulmonary fibrosis and inhibit the development of lung inflammation. The gene discussed is THY1; the disease is pulmonary fibrosis.